Products
Search Result
Home >

Products >

angiotensin 2 peptides online manufacturer Manufacturer

The search yielded  (8)  results

Angiotensin I/II (1-7) Cancer Peptides CAS 51833-78-4 Catalog Number KS084006

Angiotensin I/II (1-7),Catalog Number: KS084006,CAS NO.:51833-78-4 Angiotensin (1-7) exerts vasodilatory effects within the cardiovascular system and plays a crucial function in the renin-angiotensin system. Recently, Angiotensin II (Ang II) has been implicated in preventing SARS-CoV-2 infection by binding to ACE2 receptors in the host cell. Due to the high affinity of SARS-CoV-2 virus to ACE2 receptors, peptide-binding may potentially compete with the virus. Additionally,

Angiotensin Peptide I/II (1-7) Catalog Number KS084006 CAS 51833-78-4

Angiotensin I/II (1-7),Catalog Number: KS084006,CAS NO.: 51833-78-4 Angiotensin (1-7) exerts vasodilatory effects within the cardiovascular system and plays a crucial function in the renin-angiotensin system. Recently, Angiotensin II (Ang II) has been implicated in preventing SARS-CoV-2 infection by binding to ACE2 receptors in the host cell. Due to the high affinity of SARS-CoV-2 virus to ACE2 receptors, peptide-binding may potentially compete with the virus. Additionally,

Angiotensin I/II (1-7) Inflammation Peptides Catalog KS084006 CAS 51833-78-4

Angiotensin I/II (1-7),Catalog Number: KS084006,CAS NO.:51833-78-4 Angiotensin (1-7) exerts vasodilatory effects within the cardiovascular system and plays a crucial function in the renin-angiotensin system. Recently, Angiotensin II (Ang II) has been implicated in preventing SARS-CoV-2 infection by binding to ACE2 receptors in the host cell. Due to the high affinity of SARS-CoV-2 virus to ACE2 receptors, peptide-binding may potentially compete with the virus. Additionally,

Human Angiotensin I Cardiovascular Peptides Catalog KS092004 CAS 70937-97-2

Angiotensin I (human),Catalog Number: KS092004,CAS NO.: 70937-97-2 Angiotensin 1 (Human), an endogenous peptide substrate for angiotensin converting enzyme (ACE), is precursor to the vasoconstrictor peptide angiotensin II.

Angiotensin II (human) COVID-19 Peptides Catalog Number KS063002 CAS 4474-91-3

Angiotensin II (human),Catalog Number: KS063002,CAS NO.:4474-91-3 Angiotensin II is an endogenous potent vasoconstrictor peptide typically generated by the removal of two residues from angiotensin I by angiotensin-converting enzyme (ACE) by binding to both the AT1 and the AT2 receptors.

Angiotensin I (human) COVID-19 Peptides Catalog Number KS092004 CAS 70937-97-2

Angiotensin I (human),Catalog Number: KS092004,CAS NO.:70937-97-2 Angiotensin 1 (Human), an endogenous peptide substrate for angiotensin converting enzyme (ACE), is precursor to the vasoconstrictor peptide angiotensin II.

Angiotensin I/II (1-7) COVID-19 Peptides Catalog Number KS084006 CAS 51833-78-4

Angiotensin I/II (1-7),Catalog Number: KS084006,CAS NO.:51833-78-4 Angiotensin (1-7) exerts vasodilatory effects within the cardiovascular system and plays a crucial function in the renin-angiotensin system. Recently, Angiotensin II (Ang II) has been implicated in preventing SARS-CoV-2 infection by binding to ACE2 receptors in the host cell. Due to the high affinity of SARS-CoV-2 virus to ACE2 receptors, peptide-binding may potentially compete with the virus. Additionally,

Angiotensin I Converting Enzyme Inhibitor 2 Cardiovascular Peptides Catalog KS091001 CAS 35115-60-7

Angiotensin I Converting Enzyme Inhibitor 2,Catalog Number: KS091001,CAS NO.: 35115-60-7 Peptide capable of inhibiting the conversion of angiotensin I to angiotensin II.

1